Clark Capital Management Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-465,985
| Closed | -$41.9M | – | 453 |
|
|
2025
Q1 | $41.9M | Buy |
465,985
+34,859
| +8% | +$3.12M | 0.3% | 109 |
|
|
2024
Q4 | $34.4M | Buy |
+431,126
| New | +$37.3M | 0.24% | 123 |
|
|
2024
Q2 | – | Sell |
-429,834
| Closed | -$37.5M | – | 413 |
|
|
2024
Q1 | $37.5M | Buy |
+429,834
| New | +$36.7M | 0.28% | 109 |
|
|
2021
Q4 | – | Sell |
-216,746
| Closed | -$27.2M | – | 371 |
|
|
2021
Q3 | $27.2M | Buy |
216,746
+6,730
| +3% | +$871K | 0.37% | 111 |
|
|
2021
Q2 | $26.1M | Sell |
210,016
-169,582
| -45% | -$21.3M | 0.37% | 110 |
|
|
2021
Q1 | $44.8M | Sell |
379,598
-288,296
| -43% | -$33.8M | 0.68% | 35 |
|
|
2020
Q4 | $78.2M | Buy |
667,894
+87,133
| +15% | +$9.59M | 1.29% | 10 |
|
|
2020
Q3 | $60.4M | Buy |
580,761
+163,819
| +39% | +$16.5M | 1.14% | 16 |
|
|
2020
Q2 | $38.2M | Sell |
416,942
-122,883
| -23% | -$11.8M | 0.71% | 27 |
|
|
2020
Q1 | $48.7M | Buy |
539,825
+300,209
| +125% | +$31.9M | 1.24% | 17 |
|
|
2019
Q4 | $27.2M | Sell |
239,616
-1,644
| -0.7% | -$180K | 0.57% | 59 |
|
|
2019
Q3 | $26.2M | Sell |
241,260
-7,192
| -3% | -$750K | 0.59% | 59 |
|
|
2019
Q2 | $24.2M | Buy |
+248,452
| New | +$22.7M | 0.51% | 68 |
|
|
2019
Q1 | – | Sell |
-388,391
| Closed | -$35.3M | – | 311 |
|
|
2018
Q4 | $35.3M | Buy |
388,391
+8,421
| +2% | +$787K | 0.95% | 32 |
|
|
2018
Q3 | $37.4M | Buy |
379,970
+11,438
| +3% | +$1.06M | 0.95% | 27 |
|
|
2018
Q2 | $31.6M | Buy |
368,532
+95,648
| +35% | +$7.99M | 0.91% | 35 |
|
|
2018
Q1 | $21.9M | Buy |
+272,884
| New | +$22.5M | 0.69% | 56 |
|
|
2016
Q3 | – | Sell |
-2,551
| Closed | -$221K | – | 320 |
|
|
2016
Q2 | $221K | Sell |
2,551
-43,862
| -95% | -$3.55M | 0.01% | 280 |
|
|
2016
Q1 | $3.48M | Buy |
46,413
+37,517
| +422% | +$2.83M | 0.27% | 93 |
|
|
2015
Q4 | $684K | Sell |
8,896
-737
| -8% | -$55.5K | 0.06% | 185 |
|
|
2015
Q3 | $645K | Buy |
9,633
+1,011
| +12% | +$74.5K | 0.06% | 185 |
|
|
2015
Q2 | $639K | Buy |
8,622
+61
| +0.7% | +$4.66K | 0.06% | 193 |
|
|
2015
Q1 | $668K | Buy |
8,561
+4,917
| +135% | +$373K | 0.06% | 199 |
|
|
2014
Q4 | $263K | Buy |
+3,644
| New | +$253K | 0.02% | 268 |
|
|
2013
Q3 | – | Sell |
-3,971
| Closed | -$204K | – | 359 |
|
|
2013
Q2 | $204K | Buy |
+3,971
| New | +$196K | 0.02% | 314 |
|
Other funds holding MDT
Clark Capital Management Group's MDT Position: Q2 2025 in Review
Clark Capital Management Group sold out of Medtronic (MDT) in Q2 2025, closing a stake of 465,985 shares — an estimated $41.9M sold.
Clark Capital Management Group first reported a position in MDT in Q2 2013 and held it in 25 quarters. The position peaked at $78.2M in Q4 2020. 2,139 funds tracked by Wall St. Rank hold MDT as of Q2 2025.
- Clark Capital Management Group reported no remaining Medtronic position as of Q2 2025 after selling out during the quarter.
- Clark Capital Management Group sold 465,985 Medtronic shares in Q2 2025, an estimated $41.9M.
- Clark Capital Management Group first reported a position in Medtronic in Q2 2013 and held it in 25 quarters.
- Clark Capital Management Group's Medtronic position peaked at $78.2M in Q4 2020.
- 2,139 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.
Based on Clark Capital Management Group's 13F filing for Q2 2025, filed 14 Aug 2025.